参考文献/References:
[1] MENON DK, SCHWAB K, WRIGHT DW, et al. Demographics and clinical assessment working group of the international and interagency initiative toward common data elements for research on traumatic brain injury and psychological health. position statement: definition of traumatic brain injury [J]. Arch Phys Med Rehabil, 2010, 91(11): 1637-1640.
[2] ZHANG XH, XIA YJ. The correlation of acute phase of tethelin level of patients with traumatic brain injury with illness severity and prognosis [J]. World Latest Med Inform, 2016, 16(72): 8-9. 张秀华,夏玉军. 创伤性颅脑损伤患者的急性期垂体前叶激素水平和病情轻重及预后相关性[J]. 世界最新医学信息文摘,2016,16(72):8-9.
[3] CARNEY N, TOTTEN AM, O'REILLY C, et al. Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition [J]. Neurosurgery, 2017, 80(1): 6-15.
[4] CUI JY, ZHOU ZH, JIANG J, et al. Assessment of brain injury severity: simplified motor score vs Glasgow coma scale [J]. Chin J Clin Neurosurg, 2012, 17(7): 412-413. 崔景余,周正虎,蒋 建,等. 简易运动评分与GCS对颅脑损伤伤情评价的比较[J]. 中国临床神经外科杂志,2012,17(7):412-413.
[5] HUANG HZ, TONG HB. The progress of neuroendocrine changes following traumatic brain injury [J]. Chin J Clinicians (Electronic Edition), 2016, 10(8): 1164-1167. 黄厚智,仝海波. 创伤性脑损伤后神经内分泌变化的研究进展[J]. 中华临床医师杂志(电子版),2016,10(8):1164-1167.
[6] KOPCZAK A, KILIMANN I, VON ROSEN F, et al. Screening for hypopituitarism in 509 patients with traumatic brain injury or subarachnoid hemorrhage [J]. J Neurotrauma, 2014, 31(1): 99-107.
[7] LIANG QL, GUO YC, LI ZH. Research progress on hypopituitorism after traumatic brain injury [J]. Chin J Endocr Surg, 2019, 13(4): 339-342. 梁前垒,郭永川,李朝晖. 颅脑创伤后腺垂体功能减退的研究进展[J]. 中华内分泌外科杂志,2019,13(4):339-342.
[8] SUN ZG, YANG Y, SUN JX, et al. Prevalence of and risk factors of hypopituitarism in patients with traumatic brain injury [J]. J Clin Neurosurg, 2020, 17(6): 711-713. 孙振国,杨 阳,孙建新,等. 颅脑创伤后垂体功能减退的危险因素分析[J]. 临床神经外科杂志,2020,17(6):711-713.
[9] TAN CL, ALAVI SA, BALDEWEG SE, et al. The screening and management of pituitary dysfunction following traumatic brain injury in adults: British Neurotrauma Group guidance [J]. J Neurol Neurosurg Psychiatry, 2017, 88(11): 971-981.
[10] BOONEN E, BORNSTEIN SR, BERGHE GVD. New insights into the controversy of adrenal function during critical illness [J]. Lancet Diabetes Endocrinol, 2015, 3(10): 805-815.
[11] WANG PQ, GAO JX, CHEN JH, et al. Changes of hormone levels and related indicators at adrenocorticotrophic hormone and thyrotropic hormone axes in patients with traumatic brain injury at early stage [J]. Chin J Neuromed, 2020, 19(6): 566-575. 王碰起,高进喜,陈锦华,等. 创伤性颅脑损伤早期患者ACTH轴和TSH轴激素水平及相关指标的变化[J]. 中华神经医学杂志,2020,19(6):566-575.
[12] LIU XY, ZHAI XG, ZHEN YF, et al. Effect of serum thyroid hormone levels on mortality and severity of patients with severe traumatic brain injury [J]. China J Modern Med, 2017, 27(9): 74-77. 刘兴宇,翟晓刚,甄艳凤,等. 重型颅脑创伤后患者血清甲状腺激素水平对病情严重程度及死亡率的影响[J]. 中国现代医学杂志,2017,27(9):74-77.
[13] CLAYTON PE, CUNEO RC, JUUL A, et al. European Society of Paediatric Endocrinology: Consensus statement on the management of the GH-treated adolescent in the transition to adult care [J]. Eur J Endocrinol, 2005, 152(2): 165-170.
[14] WANG DM, CHANG J, BAI YX, et al. Relationship between changes of serum sex hormones and prognosis in patients with acute craniocerebral injury [J]. Chin J Neurosurg, 2014, 30(7): 715-717. 王冬梅,常 杰,白云贤,等. 急性颅脑损伤血清性激素水平变化与预后的研究[J]. 中华神经外科杂志,2014,30(7):715-717.
[15] TANRIVERDI F, ULUTABANCA H, UNLUHIZARCI K, et al. Pituitary functions in the acute phase of traumatic brain injury: are they related to severity of the injury or mortality [J]. Brain Inj, 2007, 21(4): 433-439.
[16] PIKE CJ, NGUYEN TV, RAMSDEN M, et al. Androgen cell signaling pathways involved in neuroprotective actions [J]. Horm Behav, 2008, 53: 693-705.
[17] LONG YF, WANG XL, WANG MP, et al. Effects of androgen on the expression of Bcl-2, Bax and Cyt-C in brain tissue of adult rat models of middle cerebral artery occlusion [J]. Chin J Tissue Engineer Res, 2019, 23(27): 4344-4349. 龙艳芳,王新蕾,王明璞,等. 雄激素干预成年雄性大脑中动脉阻断模型大鼠脑组织Bcl-2?Bax与Cyt-C的表达[J]. 中国组织工程研究, 2019,23(27):4344-4349.
[18] B RRETO G, VEIGA S, AZCOITIA I, et al. Testosterone decreases reactive astroglia and reactive microglia after brain injury in male rats: role of its metabolites, oestradiol and dihydrotestosterone [J]. Eur J Neurosci, 2007, 25(10): 3039-3046.
[19] KANWORE K, KANWORE K, GUO X, et al. Testosterone upregulates glial cell line-derived neurotrophic factor (GDNF) and promotes neuroinflammation to enhance glioma cell survival and proliferation [J]. Inflamm Regen, 2023, 43(1): 49.